Tau distribution in probable Cerebral Amyloid Angiopathy

Cerebrovascular deposition of amyloid-ß (cerebral amyloid angiopathy, CAA) is associated with magnetic resonance imaging findings of lobar hemorrhage, cerebral microbleeds, andor cortical superficial siderosis. Although pathological studies suggest that The aim was to evaluate the relationship between tau may co-localise with vascular amyloid, with relevance for understanding disease mechanisms, this has not yet been investigated in CAA in vivo. and tau in CAA patients. We therefore used Three patients with clinically diagnosed CAA underwent [C]Pittsburgh Compound B PET or [18F] Florbetaben PET to measure amyloid burden, and [F]T807 to measure paired helical filament tau in patients with probable CAA. The regions with that had cerebral microbleeds or cortical superficial siderosis largely overlapped with those showing regions that showed iincreased [F]T807 and uptake as well as increased [C]PiB uptake. Our study This provides preliminary in vivo evidence that vascular amyloid is associated with local production of paired helical filament tau.

[1]  C. DeCarli,et al.  Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage , 2015, Alzheimer's & Dementia.

[2]  Keith A. Johnson,et al.  Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.

[3]  Leonard Petrucelli,et al.  Understanding Biomarkers of Neurodegeneration: Novel approaches to detecting tau pathology , 2015, Nature Medicine.

[4]  D. Werring,et al.  Cortical superficial siderosis , 2015, Neurology.

[5]  M. Yamada Cerebral Amyloid Angiopathy: Emerging Concepts , 2015, Journal of stroke.

[6]  Kazuhiko Yanai,et al.  Tau PET Imaging in Alzheimer’s Disease , 2014, Current Neurology and Neuroscience Reports.

[7]  C. Rowe,et al.  In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  H. Kolb,et al.  [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.

[9]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[10]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[11]  J. Trojanowski,et al.  Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy , 2011, The Journal of Neuroscience.

[12]  Keith A. Johnson,et al.  Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy , 2010, Annals of neurology.

[13]  Sang Won Seo,et al.  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients , 2010, Journal of Korean medical science.

[14]  C. Rowe,et al.  11C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage , 2010, Neurology.

[15]  S. Greenberg,et al.  Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy , 2009, Annals of neurology.

[16]  S. Love,et al.  Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[17]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[18]  S. Greenberg Cerebral Amyloid Angiopathy , 2000 .

[19]  H. Vinters Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[20]  A. Delacourte Tau pathology and neurodegeneration: an obvious but misunderstood link. , 2008, Journal of Alzheimer's disease : JAD.

[21]  A. Verma,et al.  Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy , 2008 .

[22]  S. Love Contribution of cerebral amyloid angiopathy to Alzheimer's disease. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[23]  B T Hyman,et al.  Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. , 2000, Acta neuropathologica.

[24]  R. Campbell,et al.  Clinicopathologic studies of primary cerebral amyloid angiopathy. , 1979, Mayo Clinic proceedings.